PRIMA-1MET Inhibits Growth of Mouse Tumors Carrying Mutant p53
Reactivation of the tumor suppressor activity to mutant p53 should trigger massive apoptosis and eliminate tumors. The low molecular weight compounds PRIMA-1 and the structural analog PRIMA-1MET reactivate human mutant p53 in vitro and suppress growth of human tumor xenografts in SCID mice. However,...
Saved in:
| Main Authors: | Nicole Zache, Jeremy M. R. Lambert, Klas G. Wiman, Vladimir J. N. Bykov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | Cellular Oncology |
| Online Access: | http://dx.doi.org/10.3233/CLO-2008-0440 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death
by: Sophia Ceder, et al.
Published: (2020-12-01) -
Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.
by: Jonathan Wills, et al.
Published: (2011-03-01) -
Aptamers Binding to c-Met Inhibiting Tumor Cell Migration.
by: Birgit Piater, et al.
Published: (2015-01-01) -
Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET.
by: Sameer A Greenall, et al.
Published: (2012-01-01) -
Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53
by: Xiangbing Meng, et al.
Published: (2013-01-01)